About the Authors
- Pietro Guaraldi
-
* E-mail: pietro.guaraldi@unibo.it
Affiliations IRCCS, Institute of Neurological Sciences of Bologna, Bologna, Italy, Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy
- Roberto Poda
-
Affiliations IRCCS, Institute of Neurological Sciences of Bologna, Bologna, Italy, Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy
- Giovanna Calandra-Buonaura
-
Affiliations IRCCS, Institute of Neurological Sciences of Bologna, Bologna, Italy, Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy
- Laura Solieri
-
Affiliations IRCCS, Institute of Neurological Sciences of Bologna, Bologna, Italy, Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy
- Luisa Sambati
-
Affiliations IRCCS, Institute of Neurological Sciences of Bologna, Bologna, Italy, Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy
- Roberto Gallassi
-
Affiliations IRCCS, Institute of Neurological Sciences of Bologna, Bologna, Italy, Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy
- Pietro Cortelli
-
Affiliations IRCCS, Institute of Neurological Sciences of Bologna, Bologna, Italy, Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy
Competing Interests
PG reports no competing interests. RP reports no competing interests. GCB has received honoraria for speaking engagements from Lundbeck (Italia) and UCB Pharma S.p.A. L.Solieri has received honoraria for experimental study participation by Chelsea Therapeutics. L.Sambati reports no competing interests. RG reports no competing interests. PC has received honoraria for speaking engagements or consulting activities with Allergan (Italia), Boehringer Ingelheim (Italia), Chelsea Therapeutics, GlaxoSmithKline S.p.A, Lundbeck (Italia), Merck Sharp & Dohme (Italia), Teva, UCB Pharma S.p.A, Chiesi Farmaceutici and AbbVie srl. This does not alter the authors′ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: RG PC. Performed the experiments: PG RP GCB L. Sambati L. Solieri. Analyzed the data: PG RP GCB. Contributed reagents/materials/analysis tools: PG RP L. Sambati L. Solieri Wrote the paper: PG RP GCB L. Sambati RG PC.